Myelin oligodendrocyte glycoprotein antibody disease

This code represents a rare autoimmune inflammatory disorder of the central nervous system characterized by antibodies against myelin oligodendrocyte glycoprotein (MOG). It primarily affects the optic nerves, spinal cord, and brain, leading to episodes of demyelination. The disease can manifest with symptoms similar to multiple sclerosis or neuromyelitis optica spectrum disorder.

Use this code when documentation explicitly states a diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD). This diagnosis is typically confirmed by the presence of MOG antibodies in serum or cerebrospinal fluid, alongside characteristic clinical and radiological findings. This code is appropriate for both initial diagnosis and subsequent encounters related to the management of MOGAD.

• Ensure the physician's documentation clearly specifies "Myelin Oligodendrocyte Glycoprotein Antibody Disease" or "MOGAD."
• Do not confuse this with other demyelinating diseases like multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) unless MOGAD is explicitly ruled out or co-exists.
• Code any associated neurological manifestations or complications, such as optic neuritis or transverse myelitis, as secondary diagnoses.